Filing Details
- Accession Number:
- 0001179110-12-013432
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-28 19:02:48
- Reporting Period:
- 2012-08-24
- Filing Date:
- 2012-08-28
- Accepted Time:
- 2012-08-28 19:02:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1080014 | Theravance Inc | THRX | Pharmaceutical Preparations (2834) | 943265960 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1302445 | L David Brinkley | Theravance, Inc. 901 Gateway Boulevard South San Francisco CA 94080 | Head Of Business Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-08-24 | 3,483 | $27.50 | 60,241 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Dispositions made pursuant to a plan intended to comply with rule 10b5-1(c).
Billionaire Hedge Funds
